Cognitive-behavioral Treatment for Rheumatoid Arthritis
Sponsor: Chengdu PLA General Hospital
Listed as NCT02257073, this NA trial focuses on Rheumatoid Arthritis and remains ongoing. Sponsored by Chengdu PLA General Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Aug 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Aug 2020 [monthly]
Enrolling By Invitation NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chengdu PLA General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .